Overview

Single Dose Pharmacokinetics of Egalet® Hydrocodone

Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the pharmacokinetic profile of different Egalet® hydrocodone formulations and compare to a marketed hydrocodone drug.
Phase:
Phase 1
Details
Lead Sponsor:
Egalet Ltd
Treatments:
Acetaminophen
Hydrocodone